Real World Health Care concludes its series on non-small cell lung cancer by speaking with Erica Carpenter, MBA, PhD, Research Assistant Professor in the Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania. Dr. Carpenter also serves as Director of the Circulating Tumor Material Laboratory…more.
- RWHC Home
- About RWHC
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Movement Disorders
- Behavioral Health
- Multiple Myeloma
- Big Data
- Non-Small Cell Lung Cancer
- CAR-T Cell Therapy
- Nonalcoholic Steatohepatitis
- Pain Management
- Macular Degeneration
- Personalized Medicine
- Secondary Progressive MS
During the month of August, Real World Health Care will take a short break from focusing on medical breakthroughs and the researchers who are shaping the future of medicine. We will instead bring you a special series from our sponsor, the HealthWell Foundation, about what happens when families cannot afford…more.
Editor’s Note: This article originally appeared in Biotech Primer Weekly. For more information on the science behind the headlines, please subscribe. Alzheimer’s disease ranks as one of the toughest nuts to crack within drug discovery and development. Current treatments merely manage symptoms, so finding a better solution becomes more and…more.
This week, we sit down with R. Scott Turner, MD, PhD, Professor of Neurology at Georgetown University and Director of Georgetown’s Memory Disorders Program. Dr. Turner specializes in cognitive behavioral neurology, memory disorders, Alzheimer’s disease and Neurodegenerative dementias. Here, he discusses his latest research as well as the roles of…more.
Real World Health Care recently sat down with Anton Porsteinsson, MD, Department of Psychiatry, University of Rochester School of Medicine. Dr. Porsteinsson is the Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program and has devoted his career to the care and study of individuals with…more.
This week, Real World Health Care brings you a conversation with Maria Carrillo, PhD, Alzheimer’s Association Chief Scientific Officer. Formed in 1980, the Alzheimer’s Association advances research to end Alzheimer’s and dementia while enhancing care for those living with the disease. Real World Health Care: According to your literature, more…more.
This week, Real World Health Care talks with Diane Bovenkamp, Ph.D., Chief Scientific Officer for BrightFocus Foundation about the basic science and therapeutic research the Foundation is funding. Dr. Bovenkamp administers and ensures a high level of scientific accountability in the foundation’s research grant award program and scientific review process,…more.
According to a report from the Alzheimer’s Foundation of America, as many as 5.1 million Americans may have Alzheimer’s Disease (AD), a figure that is expected to triple to nearly 13.8 million by 2050. Alzheimer’s is the sixth leading cause of death in America, and individuals with AD use a…more.
In 1970, cancer was the second-leading cause of death in the United States. President Nixon made fighting this disease a priority in his 1971 State of the Union address: “I will also ask for an appropriation of an extra $100 million to launch an intensive campaign to find a cure…more.
As part of our ongoing series on big data in health care, we spoke with Bonnie Westra, Ph.D., RN, FAAN, FACMI, Associate Professor and Director, Center for Nursing Informatics, at the University of Minnesota School of Nursing. Dr. Westra is also a member of the Institute for Health Informatics and…more.